Bicara Therapeutics Inc. (BCAX)
Healthcare
Biotechnology
27.10 $
+3.2%
vs. previous close
Closing price · As of: 31. Jul 2026
Bicara Therapeutics Inc. (BCAX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -107 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -32 | -46 | -75 | -107 | |
| 0.0 | 0.0 | 0.1 | 0.4 | |
| 0.8 | 1.9 | 7.4 | 15 | |
| 4.9 | -9.6 | -14 | 15 | |
| 0.2 | 0.6 | 0.1 | 0.3 | |
| -0.2 | -0.6 | 0.0 | -318 | |
| 32 | 272 | 334 | 32 | |
| -0.6 | 226 | 259 | -393 | |
| -32 | -46 | -75 | -107 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.